1. Home
  2. BKD vs NUVB Comparison

BKD vs NUVB Comparison

Compare BKD & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookdale Senior Living Inc.

BKD

Brookdale Senior Living Inc.

HOLD

Current Price

$15.09

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.75

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKD
NUVB
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BKD
NUVB
Price
$15.09
$4.75
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$13.10
$11.22
AVG Volume (30 Days)
5.6M
4.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.09
$182.76
Revenue Next Year
$4.89
$91.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.97
$1.57
52 Week High
$17.09
$9.75

Technical Indicators

Market Signals
Indicator
BKD
NUVB
Relative Strength Index (RSI) 53.10 34.62
Support Level $14.53 $3.18
Resistance Level $17.09 $5.55
Average True Range (ATR) 0.54 0.36
MACD -0.25 -0.03
Stochastic Oscillator 21.68 31.22

Price Performance

Historical Comparison
BKD
NUVB

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: